NCT04604990 National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
| NCT ID | NCT04604990 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King Saud University |
| Condition | SLE (Systemic Lupus) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2020-12-20 |
| Primary Completion | 2050-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2020-12-20 with a primary completion date of 2050-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.
Eligibility Criteria
Inclusion Criteria: 1. Adult patients defined as age greater than 18 years old. 2. Patients should fulfil one of the following classification criteria for SLE (ACR, SLICC or ACR/EULAR criteria). 3. No restriction on time of diagnosis. Exclusion Criteria: * Patients who don't fulfil classification criteria mentioned above.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04604990 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying SLE (Systemic Lupus). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04604990 currently recruiting?
Yes, NCT04604990 is actively recruiting participants. Contact the research team at ialmaghlouth@ksu.edu.sa for enrollment information.
Where is the NCT04604990 trial being conducted?
This trial is being conducted at Riyadh, Saudi Arabia.
Who is sponsoring the NCT04604990 clinical trial?
NCT04604990 is sponsored by King Saud University. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.